«1234567»Seite
7 articles with references, page 7 of 7

cme

Insect Stings: Clinical Features and Management

Dtsch Arztebl Int 2012; 109(13): 238-48; DOI: 10.3238/arztebl.2012.0238

Przybilla, B; Ruëff, F

1. Hemmer W: Fliegen und Mücken als Auslöser kutaner, systemischer und inhalativer Allergien. Allergo J 2003; 12: S16–24.
2. Przybilla B, Ruëff F, Walker A, et al.: Diagnose und Therapie der Bienen- und Wespengiftallergie. Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI), des Ärzteverbandes Deutscher Allergologien (ÄDA), der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA), der Deutschen Dermatologischen Gesellschaft (DDG) und der Deutschen Gesellschaft für Kinder- und Jugendmedizin (DGKJ) in Zusammenarbeit mit der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI) und der Schweizerischen Gesellschaft für Allergologie und Immunologie (SGAI). Allergo J 2011; 20: 318–39.
3. Ruëff F, Przybilla B, Bilò MB, et al.: Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase – a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol 2009; 124: 1047–54. CrossRef MEDLINE
4. Rietschel E, Beyer K, Lange L, Laub O, Leupold W, Niggemann B: Anaphylaxie bei Kindern und Jugendlichen. Allergo J 2009; 18: 117–23.
5. Schäfer T: Epidemiologie der Insektengiftallergie. Allergo J 2009; 18: 353–8.
6. Hompes S, Kirschbaum J, Scherer K, et al.: Erste Daten der Pilotphase des Anaphylaxie-Registers im deutschsprachigen Raum. Allergo J 2008; 17: 550–5.
7. Pumphrey RS: Fatal posture in anaphylactic shock. J Allergy Clin Immunol 2003; 112: 451–2. MEDLINE
8. Ring J, Brockow K, Duda D, et al.: Akuttherapie anaphylaktischer Reaktionen. Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI), des Ärzteverbandes Deutscher Allergologen (ÄDA), der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA) und der Deutschen Akademie für Allergologie und Umweltmedizin (DAAU). Allergo J 2007; 16: 420–34.
9. Jappe U, Raulf-Heimsoth M, Hoffmann M, Burow G, Hübsch-Müller C, Enk A: In vitro Hymenoptera venom allergy diagnosis: improved by screening for cross-reactive carbohydrate determinants and reciprocal inhibition. Allergy 2006; 61: 1220–9. CrossRef MEDLINE
10. Niedoszytko M, de Monchy J, van Doormaal JJ, Jassem E, Oude Elberink JN: Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy. Allergy 2009; 64: 1237–45. CrossRef MEDLINE
11. Ludolph-Hauser D, Ruëff F, Fries C, Schöpf P, Przybilla B: Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings. Lancet 2001; 357: 361–2. CrossRef MEDLINE
12.Hartmann K, Biedermann T, Brockow K, et al.: Mastozytose. Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI) und der Deutschen Dermatologischen Gesellschaft (DDG). Allergo J 2009; 18: 196–207.
13. Bonifazi F, Jutel M, Bilò BM, Birnbaum J, Müller U: Prevention and treatment of Hymenoptera venom allergy: guidelines for clinical practice. Allergy 2005; 60: 1459–70. CrossRef MEDLINE
14. Valentine MD, Schuberth KC, Kagey-Sobotka A, et al.: The value of immunotherapy with venom in children with allergy to insect stings. N Engl J Med 1990; 323: 1601–3. CrossRef MEDLINE
15. Kleine-Tebbe J, Bufe A, Ebner C, et al.: Die spezifische Immuntherapie (Hyposensibilisierung) bei IgE-vermittelten allergischen Erkrankungen. Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI), des Ärzteverbandes Deutscher Allergologen (ÄDA), der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA), der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI) und der Schweizerischen Gesellschaft für Allergologie und Immunologie (SGAI). Allergo J 2009; 18: 508–37.
16. Müller U, Helbling A, Berchtold E: Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety. J Allergy Clin Immunol 1992; 89: 529–35. CrossRef MEDLINE
17. Ruëff F, Wenderoth A, Przybilla B: Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses. J Allergy Clin Immunol 2001; 108: 1027–32. CrossRef MEDLINE
18. Müller U, Mosbech H (eds): Immunotherapy with Hymenoptera venoms. Position paper. Allergy 1993; 48 (Suppl 14): 37–46. CrossRef
19. Mellanby K: Man’s reaction to mosquito bites. Nature 1946; 158: 554. CrossRef MEDLINE
20. Simons FE, Peng Z: Skeeter syndrome. J Allergy Clin Immunol 1999; 104: 705–7. CrossRef MEDLINE
21. Asada H: Hypersensitivity to mosquito bites: A unique pathogenic mechanism linking Epstein-Barr virus infection, allergy and oncogenesis. J Dermatol Sci 2007; 45: 153–60. CrossRef MEDLINE
22. Karppinen A, Brummer-Korvenkontio H, Petman L, Kautiainen H, Hervé JP, Reunala T: Levocetirizine for treatment of immediate and delayed mosquito bite reactions. Acta Derm Venereol 2006; 86: 329–31. CrossRef MEDLINE
23. Scarupa MD, Economides A: Bedbug bites masquerading as urticaria. J Allergy Clin Immunol 2006; 117: 1508–9. CrossRef MEDLINE
24. Maier H, Spiegel W, Kinaciyan T, et al.: The oak processionary caterpillar as the cause of an epidemic airborne disease: survey and analysis. Br J Dermatol 2003; 149: 990–7 CrossRef MEDLINE
25. Przybilla B, Eben R: Insektengiftallergie – Millionen von Arten als Auslöser? Allergologie 2008; 31: 361–5.
e1. Bilò MB, Ruëff F, Mosbech H, Bonifazi F, Oude-Elberink JN: Dia-gnosis of Hymenoptera venom allergy. Allergy 2005; 60: 1339–49. MEDLINE
e2. Lang DM: Anaphylactoid and anaphylactic reactions. Hazards of beta-blockers. Drug Saf 1995; 12: 299–304. MEDLINE
e3. Klein JS, Yocum MW: Underreporting of anaphylaxis in a community emergency room. J Allergy Clin Immunol 1995; 637–8. MEDLINE
e4. Pumphrey RSH, Davis S: Unter-reporting of antibiotic anaphylaxis may put patients at risk. Lancet 1999; 353: 1157–8. MEDLINE
e5. Kemp SF: The post-anaphylaxis dilemma: how long is long enough to observe a patient after resolution of symptoms? Curr Allergy Asthma Rep 2008; 8: 45–8. CrossRef MEDLINE
e6. Golden DB, Marsh DG, Kagey-Sobotka A, et al: Epidemiology of insect venom sensitivity. JAMA 1989; 262: 240–4. MEDLINE
e7. Schäfer T, Przybilla B: IgE antibodies to Hymenoptera venoms in the serum are common in the general population and are related to indications of atopy. Allergy 1996; 51: 372–7. MEDLINE
e8. Goldberg A, Confino-Cohen R: Timing of venom skin tests and IgE determinations after insect sting anaphylaxis. J Allergy Clin Immunol 1997; 100:182–4. CrossRef MEDLINE
e9. Hofmann SC, Pfender N, Weckesser S, Huss-Marp J, Jakob T: Added value of IgE detection to rApi m 1 and rVes v 5 in patients with Hymenoptera venom allergy. J Allergy Clin Immunol 2011; 127: 265–7. CrossRef MEDLINE
e10. Eberlein-König B, Varga R, Mempel M, Darsow U, Behrendt H, Ring J: Comparison of basophil activation tests using CD63 or CD203c expression in patients with insect venom allergy. Allergy 2006; 61: 1084–5. CrossRef MEDLINE
e11. Korosec P, Erzen R, Silar M, Bajrovic N, Kopac M, Kosnik M: Basophil responsiveness in patients with insect sting allergies and negative venom-specific immunoglobulin E and skin prick test results. Clin Exp Allergy 2009; 39: 1730–7. CrossRef MEDLINE
e12. Hoffmann DR, Miller JS, Sutton JL: Hymenoptera venom allergy: a geographic study. Ann Allergy 1980; 45: 276–9. MEDLINE
e13. Straumann F, Bucher C, Wüthrich B: Double sensitization to honeybee and wasp venom: immunotherapy with one or with both venoms? Value of FEIA inhibition for the identification of the cross-reacting IgE antibodies in double-sensitized patients to honeybee and wasp venom. Int Arch Allergy Immunol 2000; 123: 268–74. MEDLINE
e14. Harries MG, Kemeny DM, Youlten LJ, Mills MM, Lessof MH: Skin and radioallergosorbent tests in patients with sensitivity to bee and wasp venom. Clin Allergy 1984; 14: 407–12. MEDLINE
e15. Golden DB, Kagey-Sobotka A, Norman PS, Hamilton RG, Lichtenstein LM: Insect sting allergy with negative venom skin test responses. J Allergy Clin Immunol 2001; 107: 897–901. MEDLINE
e16. Heinig JH, Engel T, Weeke ER: Allergy to venom from bee or wasp: the relation between clinical and immunological reactions to insect stings. Clin Allergy 1988; 18: 71–8. CrossRef MEDLINE
e17. Kampelmacher MJ, Zwan JC van der: Provocation test with a living insect as a diagnostic tool in systemic reactions to bee and wasp venom: a prospective study with emphasis on the clinical aspects. Clin Allergy 1987; 17: 317–27. CrossRef MEDLINE
e18. Linden PW van der, Hack CE, Struyvenberg A, Zwan JK van der: Insect-sting challenge in 324 subjects with a previous anaphylactic reaction: current criteria for insect-venom hypersensitivity do not predict the occurrence and the severity of anaphylaxis. J Allergy Clin Immunol 1994; 94: 151–9. MEDLINE
e19. Franken HH, Dubois AE, Minkema HJ, Heide S van der, Monchy JG de: Lack of reproducibility of a single negative sting challenge response in the assessment of anaphylactic risk in patients with suspected yellow jacket hypersensitivity. J Allergy Clin Immunol 1994; 93: 431–6. CrossRef MEDLINE
e20. Hauk P, Friedl K, Kaufmehl K, Urbanek R, Forster J: Subsequent insect stings in children with hypersensitivity to Hymenoptera. J Pediatr 1995; 126:185–90. MEDLINE
e21. Haeberli G, Brönnimann M, Hunziker T, Müller U: Elevated basal serum tryptase and Hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy. Clin Exp Allergy 2003; 33: 1216–20. CrossRef MEDLINE
e22. Hunt KJ, Valentine MD, Sobotka AK, Benton AW, Amodio FJ, Lichtenstein LM: A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med 1978; 299: 157–61. MEDLINE
e23. Müller U, Thurnheer U, Patrizzi R, Spiess J, Hoigné R: Immunotherapy in bee sting hypersensitivity. Bee venom versus wholebody extract. Allergy 1979; 34: 369–78. MEDLINE
e24. Ruëff F, Przybilla B: Nebenwirkungen und Erfolg der Insektengifthyposensibilisierung. Allergo J 2005; 14: 560–8.
e25. Golden DB, Kelly D, Hamilton RG, Craig TJ: Venom immunotherapy reduces large local reactions to insect stings. J Allergy Clin Immunol 2009; 123: 1371–5. CrossRef MEDLINE
e26. Erasmus C, Blackwood W, Wilson J: Infantile multicystic encephalomalacia after maternal bee sting anaphylaxis during pregnancy. Arch Dis Child 1982; 57: 785–7. MEDLINE PubMed Central
e27. Schwartz HJ, Golden DB, Lockey RF: Venom immunotherapy in the Hymenoptera-allergic pregnant patient. J Allergy Clin Immunol 1990; 85: 709–12. MEDLINE
e28. Müller UR, Haeberli G: Use of β-blockers during immunotherapy for Hymenoptera venom allergy. J Allergy Clin Immunol 2005; 115: 606–10. CrossRef MEDLINE
e29. TenBrook JA Jr, Wolf MP, Hoffman SN, et al: Should beta-blockers be given to patients with heart disease and peanut-induced anaphylaxis? A decision analysis. J Allergy Clin Immunol 2004; 113: 977–82. MEDLINE
e30. Ruëff F, Placzek M, Przybilla B: Mastocytosis and Hymenoptera venom allergy. Curr Opin Allergy Clin Immunol 2006; 6: 284–8. CrossRef MEDLINE
e31. Ruëff F, Przybilla B, Müller U, Mosbech H: The sting challenge test in Hymenoptera venom allergy. Position paper of the Subcommittee on Insect Venom Allergy of the European Academy of Allergology and Clinical Immunology. Allergy 1996; 51: 216–25. CrossRef MEDLINE
e32. Peng Z, Xu W, Lam H, Cheng L, James AA, Simons FE: A new recombinant mosquito salivary allergen, rAed a 2: allergenicity, clinical relevance, and cross-reactivity. Allergy 2006; 61: 485–90. CrossRef MEDLINE
e33. Moffitt JE, Venarske D, Goddard J, Yates AB, Shazo RD de: Allergic reactions to Triatoma bites. Ann Allergy Asthma Immunol 2003; 91: 122–8. MEDLINE
e34. Fernández S, Fernández A, Armentia A, Pineda F: Allergy due to head lice (Pediculus humanus capitis). Allergy 2006; 61: 1372. CrossRef MEDLINE
e35. Leverkus M, Jochim RC, Schäd S, et al: Bullous allergic hypersensitivity to bed bug bites mediated by IgE against salivary nitrophorin. J Invest Dermatol 2006; 126: 91–6. MEDLINE
e36. Rolfsen W, Schröder H, Tibell C, Tibell M: Detection of specific IgE antibodies towards cat flea (Ctenocephalides felis felis) in patients with suspected cat allergy. Allergy 1987; 42: 177–181. CrossRef MEDLINE
e37. Levy Bencheton A, Berenger JM, Del Giudice P, Dalaunay P, Pages F, Morand JJ: Resurgence of bedbugs in southern France: a local problem or the tip of the iceberg? J Eur Acad Dermatol Venereol 2011; 25: 599–602. MEDLINE
e38. Benac N: Bedbug bites becoming bigger battle. CMAJ 2010; 182: 1606. CrossRef MEDLINE PubMed Central
e39. Faulde M, Dötsch W: Toxisch-irritative Dermatitis durch Prozessionsspinnerraupen nach Portugalaufenthalt. Allergologie 2005; 28: 290–5.